Overexpression of steroidogenic acute regulatory protein in rat aortic endothelial cells attenuates palmitic acid-induced inflammation and reduction in nitric oxide bioavailability

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Tian, Dai ^a   Qiu, Yanyan ^a   Zhan, Yongkun ^a   Li, Xiaobo ^a   Zhi, Xiuling ^a   Wang, Xinhong ^a   Yin, Lianhua ^a   Ning, Yanxia ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Endothelial dysfunction; Inflammation; Lipid metabolism; Nitric oxide; Palmitic acid; Steroidogenic acute regulatory protein

Indexed keywords

CERULENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEVINOLIN; NITRIC OXIDE; PALMITIC ACID; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; INFLAMMATION; LIPID METABOLISM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA, THORACIC; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; CELLS, CULTURED; CERULENIN; CHOLESTEROL; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID SYNTHESIS INHIBITORS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LOVASTATIN; MALE; NF-KAPPA B; NITRIC OXIDE; PALMITIC ACID; PHOSPHOPROTEINS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84869220720     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-144     Document Type: Article

References (49)

1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109(23 Suppl 1):III27-III32.
2. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998, 105(1A):32S-39S.
3. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006, 291(3):H985-H1002. 10.1152/ajpheart.00292.2006, 16632549.
4. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004, 15(8):1983-1992. 10.1097/01.ASN.0000132474.50966.DA, 15284284.
5. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24(6):998-1005. 10.1161/01.ATV.0000125114.88079.96, 15001455.
6. Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004, 64(1):172-178. 10.1016/j.cardiores.2004.06.020, 15364625.
7. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 2000, 20(3):744-750. 10.1161/01.ATV.20.3.744, 10712400.
8. Han SH, Quon MJ, Koh KK. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. Curr Opin Lipidol 2007, 18(1):58-65. 10.1097/MOL.0b013e328012b627, 17218834.
9. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49(11):1939-1945. 10.2337/diabetes.49.11.1939, 11078463.
10. Miller WL. StAR search-what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol 2007, 21(3):589-601.
11. Hall EA, Ren S, Hylemon PB, Rodriguez-Agudo D, Redford K, Marques D, Kang D, Gil G, Pandak WM. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. Biochim Biophys Acta 2005, 1733(2-3):111-119.
12. Borthwick F, Taylor JM, Bartholomew C, Graham A. Differential regulation of the STARD1 subfamily of START lipid trafficking proteins in human macrophages. FEBS Lett 2009, 583(7):1147-1153. 10.1016/j.febslet.2009.02.042, 19272380.
13. Ma Y, Ren S, Pandak WM, Li X, Ning Y, Lu C, Zhao F, Yin L. The effects of inflammatory cytokines on steroidogenic acute regulatory protein expression in macrophages. Inflamm Res 2007, 56(12):495-501. 10.1007/s00011-007-6133-3, 18210233.
14. Ning Y, Chen S, Li X, Ma Y, Zhao F, Yin L. Cholesterol, LDL, and 25-hydroxycholesterol regulate expression of the steroidogenic acute regulatory protein in microvascular endothelial cell line (bEnd.3). Biochem Biophys Res Commun 2006, 342(4):1249-1256. 10.1016/j.bbrc.2006.02.093, 16516145.
15. Ning YX, Ren SL, Zhao FD, Yin LH. Overexpression of the steroidogenic acute regulatory protein increases the expression of ATP-binding cassette transporters in microvascular endothelial cells (bEnd.3). J Zhejiang Univ Sci B 2010, 11(5):350-356. 10.1631/jzus.B0900369, 2865837, 20443213.
16. Ning Y, Bai Q, Lu H, Li X, Pandak WM, Zhao F, Chen S, Ren S, Yin L. Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages. Atherosclerosis 2009, 204(1):114-120. 10.1016/j.atherosclerosis.2008.09.006, 2761493, 18945429.
17. Ning Y, Xu L, Ren S, Pandak WM, Chen S, Yin L. StAR overexpression decreases serum and tissue lipids in apolipoprotein E-deficient mice. Lipids 2009, 44(6):511-519. 10.1007/s11745-009-3299-1, 2911774, 19373502.
18. Ciapaite J, van Bezu J, van Eikenhorst G, Bakker SJ, Teerlink T, Diamant M, Heine RJ, Krab K, Westerhoff HV, Schalkwijk CG. Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochim Biophys Acta 2007, 1771(2):147-154. 10.1016/j.bbalip.2006.12.005, 17240190.
19. Kim F, Tysseling KA, Rice J, Pham M, Haji L, Gallis BM, Baas AS, Paramsothy P, Giachelli CM, Corson MA, et al. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 2005, 25(5):989-994. 10.1161/01.ATV.0000160549.60980.a8, 15731493.
20. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, Shen YH. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 2006, 55(8):2301-2310. 10.2337/db05-1574, 16873694.
21. Wang XH, Chen SF, Jin HM, Hu RM. Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats. Life Sci 2009, 84(7-8):240-249.
22. Chen SF, Li SH, Ding FY. Three drugs inhibit phospholipase A2-induced high permeability of endothelial monolayers. Zhongguo Yao Li Xue Bao 1994, 15(4):299-302.
23. Ren S, Hylemon P, Marques D, Hall E, Redford K, Gil G, Pandak WM. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J Lipid Res 2004, 45(11):2123-2131. 10.1194/jlr.M400233-JLR200, 15342684.
24. Azekoshi Y, Yasu T, Watanabe S, Tagawa T, Abe S, Yamakawa K, Uehara Y, Momomura S, Urata H, Ueda S. Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 2010, 56(1):136-142. 10.1161/HYPERTENSIONAHA.110.153056, 20530293.
25. Huang J, Lu C, Chen S, Hua L, Qian R. Postnatal ontogenesis of clock genes in mouse suprachiasmatic nucleus and heart. Lipids Health Dis 2010, 9:22. 10.1186/1476-511X-9-22, 2848141, 20202222.
26. Miller WL. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim Biophys Acta 2007, 1771(6):663-676. 10.1016/j.bbalip.2007.02.012, 17433772.
27. Chan DI, Vogel HJ. Current understanding of fatty acid biosynthesis and the acyl carrier protein. Biochem J 2010, 430(1):1-19. 10.1042/BJ20100462, 20662770.
28. Goedeke L, Fernandez-Hernando C. Regulation of cholesterol homeostasis. Cell Mol Life Sci 2012, 69(6):915-930. 10.1007/s00018-011-0857-5, 22009455.
29. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol 2009, 29(4):431-438. 10.1161/ATVBAHA.108.179564, 2740366, 19299327.
30. Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 2009, 50(Suppl):S138-S143. 2674721, 19047759.
31. Guo GL, Santamarina-Fojo S, Akiyama TE, Amar MJ, Paigen BJ, Brewer B, Gonzalez FJ. Effects of FXR in foam-cell formation and atherosclerosis development. Biochim Biophys Acta 2006, 1761(12):1401-1409. 10.1016/j.bbalip.2006.09.018, 1751860, 17110163.
32. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 2009, 29(9):1370-1375. 10.1161/ATVBAHA.109.188813, 2775080, 19542021.
33. Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, McCann B. One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med 2000, 225(3):191-199. 10.1046/j.1525-1373.2000.22524.x, 11082213.
34. DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012, 246(1):379-400. 10.1111/j.1600-065X.2012.01099.x, 22435567.
35. Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 2012, 22(11):557-566. 10.1016/j.tcb.2012.08.001, 22995730.
36. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132(3):344-362. 10.1016/j.cell.2008.01.020, 18267068.
37. Ajuwon KM, Spurlock ME. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 2005, 135(8):1841-1846.
38. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000, 49(7):1231-1238. 10.2337/diabetes.49.7.1231, 10909983.
39. Li H, Bao Y, Zhang X, Yu Y. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-kappaB pathway in rat aorta. Int J Cardiol 2011, 152(2):218-224. 10.1016/j.ijcard.2010.07.019, 20692055.
40. Aragones G, Saavedra P, Heras M, Cabre A, Girona J, Masana L. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012, 11(1):72. 10.1186/1475-2840-11-72, 3503556, 22709426.
41. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006, 116(7):1793-1801. 10.1172/JCI29069, 1483173, 16823477.
42. Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK, Fowlkes JL. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol 2010, 9:73. 10.1186/1475-2840-9-73, 2988002, 21054880.
43. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2010, 9:9. 10.1186/1475-2840-9-9, 2837624, 20158910.
44. Saito T, Hasegawa Y, Ishigaki Y, Yamada T, Gao J, Imai J, Uno K, Kaneko K, Ogihara T, Shimosawa T, et al. Importance of enothelial NF-kappaB signalling in vascular remodelling and aortic aneurysm formation. Cardiovasc Res 2012, Epub ahear print.
45. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104(22):2673-2678. 10.1161/hc4601.099485, 11723017.
46. Rebolledo A, Rebolledo OR, Marra CA, Garcia ME, Roldan Palomo AR, Rimorini L, Gagliardino JJ. Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue. Cardiovasc Diabetol 2010, 9(1):65. 10.1186/1475-2840-9-65, 2974659, 20964827.
47. Razny U, Kiec-Wilk B, Wator L, Polus A, Dyduch G, Solnica B, Malecki M, Tomaszewska R, Cooke JP, Dembinska-Kiec A. Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol 2011, 10:68. 10.1186/1475-2840-10-68, 3212914, 21781316.
48. Banerjee A, Anjum S, Verma R, Krishna A. Alteration in expression of estrogen receptor isoforms alpha and beta, and aromatase in the testis and its relation with changes in nitric oxide during aging in mice. Steroids 2012, 77(6):609-620. 10.1016/j.steroids.2012.02.004, 22366072.
49. Mondillo C, Pagotto RM, Piotrkowski B, Reche CG, Patrignani ZJ, Cymeryng CB, Pignataro OP. Involvement of nitric oxide synthase in the mechanism of histamine-induced inhibition of Leydig cell steroidogenesis via histamine receptor subtypes in Sprague-Dawley rats. Biol Reprod 2009, 80(1):144-152. 10.1095/biolreprod.108.069484, 18768916.